Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07382076 · ClinicalTrials.gov registry record
Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population
A clinical trial of Activated Clotting Time, sponsored by Abbott Point of Care.
- Active
- Registry status
- 500
- Enrollment target
- 11
- Study locations
NCT07382076 is a study of Activated Clotting Time that is active but no longer recruiting, run by Abbott Point of Care. The registered enrollment target is 500 participants. The trial reports 11 study locations across 10 states.
The verdict
NCT07382076, a study of Activated Clotting Time, is active but no longer recruiting, sponsored by Abbott Point of Care.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 11
- Study locations
Study Summary
Measuring Activated Clotting Time (ACT) using the i-STAT ACTpro cartridge on the i-STAT 1 analyzer compared to a comparator device.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood draw
Study Locations (11)
Pennsylvania
- Penn State University Hershey Medical Center - Hershey
- Thomas Jefferson University - Philadelphia
Arizona
- Dignity Health Chandler Regional Medical Center - Chandler
California
- University of California at San Francisco - San Francisco
District of Columbia
- George Washington University - Washington D.C.
Kentucky
- Kentucky Clinical Trials Laboratory - Louisville
Maryland
- University of Maryland - Baltimore
Minnesota
- Minneapolis Heart Institute - Minneapolis
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-12-15 |
| Est. Completion | 2026-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07382076
The ClinicalTrials.gov registry entry for NCT07382076 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Point of Care, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Activated Clotting Time appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT07382076 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Pennsylvania, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT07382076 about?
NCT07382076 is a clinical study titled "Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population". Measuring Activated Clotting Time (ACT) using the i-STAT ACTpro cartridge on the i-STAT 1 analyzer compared to a comparator device.
What is the current status of trial NCT07382076?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2023-12-15. Estimated completion is 2026-03-30.
What conditions does trial NCT07382076 study?
This clinical trial studies the following conditions: Activated Clotting Time.
What interventions are being tested in trial NCT07382076?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07382076?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07382076 being conducted?
This trial has 11 study locations across Arizona, California, District of Columbia, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.